Eric W Roberts bought $42k of CALC
Chief Business Officer at CalciMedica, Inc.. 14,949 shares at an average of $2.82, traded Nov 3, 2023, filed Nov 7, 2023.
Score components
- +15RoleOfficer
- +6Trade size$42k at market
- +10Relative to holdingsHoldings up 90%
- +8Price context51% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- -5Track recordMedian 6-month excess return -44% over 18 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +4.2%, 3m +63.4%, 6m +69.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001209191-23-054635, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 3, 2023 | POpen-market purchase Common Stock | +3,700 | $2.77 | $10k | 20,287 | Nov 7, 2023 |
| Nov 3, 2023 | POpen-market purchase Common Stockindirect: By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA | +11,249 | $2.83 | $32k | 33,494 | Nov 7, 2023 |
Related signals
Other insiders at CalciMedica, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | CALCbuy CalciMedica, Inc. | Fred A Middleton director, owner | $200k 248,972 shares | +31% | |
| 28Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $7,675 2,500 shares | +3% | |
| 28Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $9,105 3,400 shares | +4% | |
| 31Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $16k 5,000 shares | +7% | |
| 24Weak | CALCbuy CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $7,378 2,343 shares | +3% | |
| 44Moderate | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $29k 10,000 shares | +16% | |
| 39Weak | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $9,797 3,508 shares | +6% | |
| 44Moderate | CalciMedica, Inc. | Sudarshan Hebbar Chief Medical Officer | $27k 9,563 shares | +18% | |
| 39Weak | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $8,230 3,000 shares | +6% | |
| 39Weak | CalciMedica, Inc. | Eric W Roberts CHIEF BUSINESS OFFICER | $15k 5,076 shares | +10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.